Evidence map›Paper›PMID 37296594›Full record

ArticleCells2023

Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem Cells.

Hiroki Kawano, Yuko Kawano, Chen Yu, Mark W LaMere, Matthew J McArthur, Michael W Becker, Scott W Ballinger, Satoshi Gojo, Roman A Eliseev, Laura M Calvi

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Hiroki KawanoDivision of Hematology/Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Yuko KawanoJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Chen YuCenter for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Mark W LaMereDivision of Hematology/Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Matthew J McArthurCenter for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Michael W BeckerDivision of Hematology/Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Scott W BallingerDivision of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Satoshi GojoDepartment of Regenerative Medicine, Kyoto Prefectural University of Medicine, Kyoto 602-0841, Japan.ORCID 0000-0001-8115-7816
Roman A EliseevCenter for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.ORCID 0000-0002-6783-7388
Laura M CalviJames P. Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
University of Rochester · USKyoto Prefectural University of Medicine · JPUniversity of Alabama at Birmingham · US

Funding

Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
Mechanisms of marrow microenvironmental aging and their impact of progression of clonal hematopoiesisR01AG079556 · NIA · UNIVERSITY OF ROCHESTER · PI Laura M Calvi, JANE L. LIESVELD · 2022 to 2026
$2.7M
Efferocytosis by Bone Marrow Stromal Cells and Bone AgingR01AG076786 · NIA · UNIVERSITY OF ROCHESTER · PI Laura M Calvi, Roman Eliseev · 2022 to 2026
$2.4M
Mitochondrial metabolism and bone formationR01AR072601 · NIAMS · UNIVERSITY OF ROCHESTER · PI ELISEEV, ROMAN · 2018 to 2022
$1.7M
NIAMS NIH HHS P30 AR069655NIAMS NIH HHS R01 AR072601NIA NIH HHS R01 AG076786NIA NIH HHS R01 AG079556NIH HHS AG076786, AR080291, AR061307
6 · The paper itself

Abstract

Mitochondrial dysfunction is observed in various conditions, from metabolic syndromes to mitochondrial diseases. Moreover, mitochondrial DNA (mtDNA) transfer is an emerging mechanism that enables the restoration of mitochondrial function in damaged cells. Hence, developing a technology that facilitates the transfer of mtDNA can be a promising strategy for the treatment of these conditions. Here, we utilized an ex vivo culture of mouse hematopoietic stem cells (HSCs) and succeeded in expanding the HSCs efficiently. Upon transplantation, sufficient donor HSC engraftment was attained in-host. To assess the mitochondrial transfer via donor HSCs, we used mitochondrial-nuclear exchange (MNX) mice with nuclei from C57BL/6J and mitochondria from the C3H/HeN strain. Cells from MNX mice have C57BL/6J immunophenotype and C3H/HeN mtDNA, which is known to confer a higher stress resistance to mitochondria. Ex vivo expanded MNX HSCs were transplanted into irradiated C57BL/6J mice and the analyses were performed at six weeks post transplantation. We observed high engraftment of the donor cells in the bone marrow. We also found that HSCs from the MNX mice could transfer mtDNA to the host cells. This work highlights the utility of ex vivo expanded HSC to achieve the mitochondrial transfer from donor to host in the transplant setting.

Indexed as

Hematopoietic Stem Cell TransplantationAnimalsDNA, MitochondrialHematopoietic Stem CellsMiceMice, Inbred C3HMice, Inbred C57BLMitochondriaDNA, Mitochondrialex vivo HSC expansion 3in vivo mitochondrial transfermitochondrial DNA 2MNX mouse, 5

Identifiers

PMID37296594
PMCPMC10252267
OpenAlexW4378175489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.